Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder
- PMID: 7714224
- DOI: 10.1097/00004714-199502000-00005
Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder
Abstract
Clinical data and uncontrolled observations have suggested that fluoxetine is helpful in some patients with borderline personality disorder. This article describes the results of a 13-week double-blind study of volunteer subjects with mild to moderately severe borderline personality disorder. Thirteen fluoxetine recipients and nine placebo recipients received treatment. Pretreatment and posttreatment measures were obtained for global mood and functioning, anger, and depression. The most striking finding from this study was a clinically and statistically significant decrease in anger among the fluoxetine recipients. This decrease was independent of changes in depression. These data support previous observations that fluoxetine may reduce anger in patients with borderline personality disorder. The number of subjects in this study was small, the placebo responsiveness was high, and the clinical characteristics of the patients were in the mild to moderate range of severity. The data cannot be extrapolated to more severely ill borderline patients, but further study of fluoxetine and other selective serotonin reuptake inhibitors is indicated in this population.
Similar articles
-
Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder.J Clin Psychiatry. 2004 Mar;65(3):379-85. doi: 10.4088/jcp.v65n0314. J Clin Psychiatry. 2004. PMID: 15096078 Clinical Trial.
-
[Fluoxetine in the treatment of borderline personality disorder].Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1997 Nov-Dec;25(6):391-5. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1997. PMID: 9477607 Clinical Trial. Spanish.
-
A preliminary trial of fluoxetine in refractory borderline patients.J Clin Psychopharmacol. 1991 Apr;11(2):116-20. J Clin Psychopharmacol. 1991. PMID: 2056138
-
Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.J Pers Disord. 2009 Apr;23(2):156-74. doi: 10.1521/pedi.2009.23.2.156. J Pers Disord. 2009. PMID: 19379093 Review.
-
Pharmacological interventions for people with borderline personality disorder.Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005653. doi: 10.1002/14651858.CD005653. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2010 Jun 16;(6):CD005653. doi: 10.1002/14651858.CD005653.pub2 PMID: 16437535 Updated. Review.
Cited by
-
Impulsive aggression in borderline personality disorder.Curr Psychiatry Rep. 2000 Feb;2(1):56-61. doi: 10.1007/s11920-000-0043-1. Curr Psychiatry Rep. 2000. PMID: 11122933 Review.
-
Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: a protocol for a systematic review and meta-analysis.BMJ Open. 2019 May 1;9(4):e025145. doi: 10.1136/bmjopen-2018-025145. BMJ Open. 2019. PMID: 31048431 Free PMC article.
-
Recent developments in research of trauma and personality disorders.Curr Psychiatry Rep. 2001 Feb;3(1):52-8. doi: 10.1007/s11920-001-0073-3. Curr Psychiatry Rep. 2001. PMID: 11177760 Review.
-
Efficacy and tolerability of pharmacotherapies for borderline personality disorder.CNS Drugs. 2008;22(8):671-92. doi: 10.2165/00023210-200822080-00005. CNS Drugs. 2008. PMID: 18601305 Review.
-
Pharmacotherapy for Borderline Personality Disorder: an Update of Published, Unpublished and Ongoing Studies.Curr Psychiatry Rep. 2020 Jun 5;22(8):37. doi: 10.1007/s11920-020-01164-1. Curr Psychiatry Rep. 2020. PMID: 32504127 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
